Significant Ownership of EVENTIDE ASSET MANAGEMENT, LLC

Signature - Title
/s/ Peter J. Luiso - Peter J. Luiso, General Counsel
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by EVENTIDE ASSET MANAGEMENT, LLC.

Notify me when EVENTIDE ASSET MANAGEMENT, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of EVENTIDE ASSET MANAGEMENT, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BBNX Beta Bionics, Inc. Common Stock 11% $52,456,043 4,857,041 Eventide Asset Management, LLC 31 Jan 2025
XMTR Xometry, Inc. Class A Common Stock, par value $0.000001 per share 6.7% $78,356,159 3,151,897 Eventide Asset Management, LLC 31 Dec 2024
COLL Collegium Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 5.9% $85,425,162 1,876,239 Eventide Asset Management, LLC 31 Dec 2025
Inventiva S.A. Ordinary Shares, nominal value Euro 0.01 per share 4.6% 9,368,517 -7.4% Eventide Asset Management, LLC 31 Dec 2025
MIRM Mirum Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 4.1% $165,372,042 -$40,549,990 2,093,582 -20% Eventide Asset Management, LLC 31 Dec 2025
LXEO Lexeo Therapeutics, Inc. Common Stock, $0.0001 par value per share 3.7% $4,544,189 1,234,834 Eventide Asset Management, LLC 31 Dec 2024
NKTR Nektar Therapeutics Common Stock, $0.0001 par value 3.6% $4,921,000 6,650,000 Eventide Asset Management, LLC 31 Dec 2024
INZY Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share 3.5% $2,353,200 2,220,000 Eventide Asset Management, LLC 31 Dec 2024
CLDX Celldex Therapeutics, Inc. Common Stock, par value $0.001 2% $30,459,938 1,356,186 Eventide Asset Management, LLC 30 Jun 2025
EVH Evolent Health, Inc. Class A Common Stock, par value $0.01 per share 0% $7,109 -$26,106,812 1,713 -100% Eventide Asset Management, LLC 31 Dec 2025
AURA Aura Biosciences, Inc. Common Stock, par value $0.00001 per share 0% $0 -$22,524,940 0 -100% Eventide Asset Management, LLC 31 Mar 2025
ZNTL Zentalis Pharmaceuticals, Inc. Common Stock, $0.001 par value per share 0% $0 -$6,399,327 0 -100% Eventide Asset Management, LLC 31 Mar 2025
VYNE VYNE Therapeutics Inc. Common Stock, par value $0.0001 0% $0 -$619,615 0 -100% Eventide Asset Management, LLC 30 Sep 2025

Schedules 13D/G Reported by EVENTIDE ASSET MANAGEMENT, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.